Role of polyamines in regulation of uterine blood flow of ovariectomized rats

Cyclic changes of plasma spermine concentrations in women

Based on previous studies which suggest that blood polyamines fluctuate during the menstrual cycle, the present study was set to determine whether plasma concentrations of the polyamine spermine show menstrual cycle-associated changes and if so, how these changes relate to phasic variations in other female hormones. Blood samples were collected from a group of 9 healthy women of various ages at 5 defined periods during their menstrual cycle including 1 woman on oral contraceptives. Spermine concentrations were determined in plasma acid extracts by reversed-phase high performance liquid chromatography method. Plasma estradiol, LH and FSH were measured by microparticle enzyme immunoassay using an automatic analyzer. Spermine concentrations, 104.4 +/- 12.2 nmol/ml at 1-3 day of the cycle, were increased transiently with a peak (263.8 +/- 22.1 nmol/ml) at 8-10 day and declined to 85.4 +/- 29.8 nmol/ml by 21-23 day of the cycle. The peak spermine concentrations coincided with the first increase in plasma estrogen levels. The individual variations in the temporal profile of spermine concentrations were of similar magnitude as individual differences in other female hormones. We conclude that: a) Plasma spermine concentrations undergo distinct cyclic alterations during the menstrual cycle with peak concentrations coinciding with the first estradiol increase, and b) Peak plasma spermine concentrations occur during the follicular phase, just prior to ovulation, during the period of rapid endometrial growth.

The impact of polyamine analogues on the blood pressure of normotensive and hypertensive rats

The impact of the antineoplastic polyamine analogues N1N14-diethylhomospermine (DEHSPM) and N1N11-diethylnorspermine (DENSPM) on the blood pressure and heart rate of normotensive and hypertensive rats are described. DEHSPM was administered to both normotensive and spontaneously hypertensive rats (SHR), while the DENSPM analogue was given only to the normotensive animals. The intravenous administration of DEHSPM at doses of 5 or 10 mg/kg resulted in a profound and long-lasting drop in the test animals' blood pressure, with no appreciable change in their heart rate. This was true for both the normotensive and the hypertensive animals. When administered at equivalent molar dosages, DENSPM was one fifth as effective as DEHSPM at reducing blood pressure. The impact of NG-nitro-L-arginine-methyl ester (L-NAME) and L-arginine on the analogues' activity is consistent with the involvement of nitric oxide.

Extracellular and intracellular effects of polyamines on smooth muscle contractions

The natural polyamines spermine, spermidine and putrescine, and their metabolic products N1-acetylspermine (N-AS) and 5'-deoxi-5'-methyl-thioadenosine (DMT), but not N1-acetylspermidine nor N-acetylputrescine, relax the KCl-induced contraction in rat uterus in a dose-dependent way. This relaxing effect is counteracted by CaCl2 (0.1-6 mM) but not by Bay K 8644. Spermine, N-AS and DMT also inhibit the contraction induced by methacholine and PGF2 alpha. Spermine, DMT and N-AS relax the vanadate-induced contraction in uterus incubated in calcium-free solution plus EDTA. However, in the vanadate contraction, the EC50s are higher than those obtained with other contracturants. These results suggest that polyamines inhibit smooth muscle contraction by action at plasma membrane level decreasing the influx of calcium. However, intracellular actions of polyamines could also be involved in their effects.

Non-genomic effects of catecholestrogens in the in vitro rat uterine contraction

1. The effects of catecholestrogens 2-hydroxyestradiol (2-OH E2, 0.6-30 microM), 4-hydroxyestradiol (4-OH E2, 1-30 microM) and 2-methoxyestradiol (2-MeO E2, 0.6-30 microM) on rat uterine contraction induced by KCl (60 mM), have been assayed. 2. All drugs assayed relaxed the tonic-contraction induced by KCl in a concentration-dependent way. The EC50s were: 4.4 +/- 0.5, 4.2 +/- 0.3 and 8.5 +/- 0.7 microM for 2-MeO E2, 2-OH E2 and 4-OH E2, respectively. This relaxing effect was counteracted by CaCl2 (1-10 mM) but not by the calcium channel agonist Bay k 8644 (1 nM-1 microM). 3. The effect of 2-MeO E2 is not modified by propranolol (1 microM), cycloheximide (35 microM), actinomycin D (4 microM), alpha-difluoromethyl-ornithine (10 mM) or genistein (10 microM). Nor did cycloheximide (35 microM) or actinomycin D (4 microM) modify the relaxing effect of 2-OH E2 and 4-OH E2. Propranolol (1 microM) significantly increased the effect of 4-OH E2 but not the effect of 2-OH E2. 4. Our results suggest that the relaxing effect of catecholestrogens in the rat uterus is a non-genomic effect and could be related to inhibition of extracellular calcium entry.